To percutaneously deliver a replacement tricuspid valve, a cable is percutaneously positioned with a first end extending out of the venous vasculature at the neck, and a second end extending out of a femoral access point. An eyehook device is positioned over the first end. A tricuspid valve delivery device (TVDD) is advanced over the second end, and then advanced through an IVC into a right atrium. The eyehook device is advanced into the right ventricle, drawing an intermediate portion of the cable into the right ventricle. Contact between the distal end of the eyehook device and the right ventricle is maintained while the TVDD is pushed from the femoral vein. The intermediate portion of cable applies a force to a distal nose of the TVDD that causes the distal nose to be steered into a tricuspid valve annulus as the TVDD is advanced.
A system and method used to deliver a percutaneous ventricular assist device (pVAD) or other cardiac therapeutic device to a site within the heart, such as a site at the aortic valve. A flexible device is percutaneously introduced into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The venous-side end of the flexible device is withdrawn out the venous vasculature superior to the heart, and a pVAD is secured to the flexible device. The pVAD is pushed in a distal direction while the arterial-side end of the flexible device is pulled in the proximal direction to advance the pVAD to the target site. A left ventricle redirector aids in orienting the pVAD and preventing migration of the flexible member towards delicate structures of the heart during advancement of the pVAD.
A61M 60/237 - Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly axial components, e.g. axial flow pumps
A61M 60/148 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
A61M 60/216 - Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
A61M 60/13 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel by means of a catheter allowing explantation, e.g. catheter pumps temporarily introduced via the vascular system
A61M 60/865 - Devices for guiding or inserting pumps or pumping devices into the patient’s body
A system and method for extracting a pVAD device that is implanted with a distal portion in an aorta of the heart and a drive line extending across an inter-atrial septum and out of the body via a superior vessel of the venous vasculature, include a first device that is introduced into a femoral artery and through the descending aorta used to engage a distal part of the pVAD device in the aorta of a patient using an instrument. A second, cutter, device is introduced into the venous vasculature superior to heart, advanced to a position adjacent the inter-atrial septum, and used to cut the pVAD drive line adjacent to the inter-atrial septum. After cutting, a first portion of the pVAD is withdrawn from the body via the venous vasculature, and a second portion is withdrawn from the body via the femoral artery.
A61M 1/00 - Suction or pumping devices for medical purposesDevices for carrying-off, for treatment of, or for carrying-over, body-liquidsDrainage systems
A61M 1/12 - Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps implantable into the body
5.
Percutaneous sheaths for use with percutaneous ventricular assist devices
Percutaneous access sheaths used to provide access to the vasculature and heart for the introduction of percutaneous ventricular assist devices (pVADs), and to remain in place for the duration of pVAD use. The sheaths include actively closeable seals engageable to seal against the drive lines of the pVADs to minimize blood loss during pVAD use.
A61M 60/148 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
A system and method used to deliver an aortic valve therapeutic device to an aortic valve site includes a cable percutaneously introduced a cable into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transeptal puncture, and to a femoral artery. The therapeutic device is passed over an end of the cable at the venous side and is secured to the cable. The therapeutic device is pushed in a distal direction while the second end of the cable is pulled in the proximal direction to advance the therapeutic device to the mitral valve site. A left ventricle redirector aids in orienting the therapeutic device and preventing migration of the cable towards delicate mitral valve structures and chordae tendoneae during advancement of the therapeutic device.
Systems and methods for transseptal delivery of percutaneous ventricular assist devices and other non-guidewire based transvascular therapeutic devices
A system and method used to deliver a percutaneous ventricular assist device (pVAD) or other cardiac therapeutic device to a site within the heart, such as a site at the aortic valve. A flexible device is percutaneously introduced into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The venous-side end of the flexible device is withdrawn out the venous vasculature superior to the heart, and a pVAD is secured to the flexible device. The pVAD is pushed in a distal direction while the arterial-side end of the flexible device is pulled in the proximal direction to advance the pVAD to the target site. A left ventricle redirector aids in orienting the pVAD and preventing migration of the flexible member towards delicate structures of the heart during advancement of the pVAD.
An instrument for facilitating transseptal delivery of a cardiac therapeutic device is positionable in a left ventricle. The instrument includes an elongate shaft having a tubular lumen, the shaft having a proximal portion and a distal portion actively steerable between a generally straight position and a curved position. An external pull wire and an internal pull wire are each actuatable to move the distal portion to the curved position. The external pull wire extends internally through the proximal portion of the shaft and longitudinally along the exterior of the distal portion of the shaft, while the internal pull wire extends internally through the proximal portion of the shaft adjacent to the external pull wire, and extends internally through the distal portion of the shaft.
A61M 60/135 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting
A61M 60/148 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
A61B 17/00 - Surgical instruments, devices or methods
9.
SYSTEMS AND METHODS FOR TRANS SEPTAL DELIVERY OF PERCUTANEOUS VENTRICULAR ASSIST DEVICES AND OTHER NON-GUIDEWIRE BASED TRANSVASCULAR THERAPEUTIC DEVICES
The presently disclosed system directly steers a percutaneous ventricular assist devices (pVAD) delivery system and guides it forward from the front of the device. This unique approach gives greater control over the movement of the pVAD into and through the heart. It includes components that allow the user to both push the proximal end of the pVAD while simultaneously pulling and directly steering on the distal tip of it with equal and coordinated force to drive the pVAD safely across the interatrial septum and through the heart. Features of the system specifically apply a strong steering force that draws the distal nose of the pVAD medially and inferiorly away from protrusion into delicate cardiac tissues.
A conduit for creating a passage from a right atrium to a left atrium, through a mitral valve into the left ventricle, and to provide a passage from the left ventricle into the aortic valve. The conduit includes an elongate tubular member having a shaft with a proximal section and a distal loop section at a distal end of the proximal section. The distal loop section includes a proximal curve, a distal curve, a generally straight segment extending between the curves, and a distal tip. The shaft in the distal loop section curves back on itself so that proximal curve is formed by a part of the shaft that is closer along the length of the shaft to the distal tip. The shapes of the proximal and distal curves are selected to direct the distal tip into the mitral valve after it has crossed the inter-atrial septum from the right atrium to the left atrium of the heart, and to orient the distal opening of the distal tip towards the aortic valve when the proximal curve is in the mitral valve and the distal tip is in the left ventricle.
A61M 60/135 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting
A61M 60/148 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
A61B 17/00 - Surgical instruments, devices or methods
11.
Systems and methods for transseptal delivery of percutaneous ventricular assist devices and other non-guidewire based transvascular therapeutic devices
A system and method used to deliver a percutaneous ventricular assist device (pVAD) or other cardiac therapeutic device to a site within the heart, such as a site at the aortic valve. A flexible device is percutaneously introduced into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The venous-side end of the flexible device is withdrawn out the venous vasculature superior to the heart, and a pVAD is secured to the flexible device. The pVAD is pushed in a distal direction while the arterial-side end of the flexible device is pulled in the proximal direction to advance the pVAD to the target site. A left ventricle redirector aids in orienting the pVAD and preventing migration of the flexible member towards delicate structures of the heart during advancement of the pVAD.
A61M 60/135 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting
A61M 60/148 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
12.
Guidewireless transseptal delivery system and method
A system and method used to deliver a therapeutic device to a target treatment site in the heart includes a cable percutaneously introduced a cable into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The therapeutic device is passed over an end of the cable at the venous side and is secured to the cable. The therapeutic device is pushed in a distal direction while the second end of the cable is pulled in the proximal direction to advance the therapeutic device to the target treatment site. A left ventricle redirector aids in orienting the therapeutic device and preventing migration of the cable towards delicate mitral valve structures and chordae tendoneae during advancement of the therapeutic device.
A system and method used to deliver therapeutic device of the heart (TDH) to a site within the heart, such as a site at the aortic valve. A cable is percutaneously introduced into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The venous-side end of the cable is then withdrawn out the venous vasculature superior to the heart, and a TDH is secured to the cable. The TDH is pushed in a distal direction while the arterial-side end of the cable is pulled in the proximal direction to advance the TDH to the target site. A left ventricle redirector aids in orienting the TDH and preventing migration of the cable towards delicate structures of the heart during advancement of the TDH.
A system and method used to deliver a mitral valve therapeutic device (MVTD) to a mitral valve site includes a cable percutaneously introduced a cable into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The MVTD is passed over an end of the cable at the venous side and is secured to the cable. The MVTD is pushed in a distal direction while the second end of the cable is pulled in the proximal direction to advance the MVTD to the mitral valve site. A left ventricle redirector aids in orienting the MVTD and preventing migration of the cable towards delicate mitral valve structures and chordae tendoneae during advancement of the MVTD.
A device for facilitating use of instruments disposed through an aortic arch includes an embolic deflector having a first surface positionable in contact with a wall of an aortic arch such that a porous barrier portion of the embolic deflector covers ostia of at least the brachiocephalic and left common carotid arteries. A second surface is disposed on an opposite face from the first surface. A lubricious guide track is disposed on the second surface and extends longitudinally on the embolic deflector. The deflector and/or guide track is supported by a shaft that is extendable through a femoral artery and descending aorta to position the guide within the aortic arch. During use, the device is percutaneously introduced via the femoral artery and advanced into the aorta. The porous barrier portion of the deflector is positioned over the target ostia, and the guide track thus faces into the aortic arch. An instrument passed through the aortic arch, such as an aortic valve delivery system introduced via a femoral artery, is advanced along the lubricious guide track towards a target site (e.g. the aortic valve), minimizing contact between the instrument and the wall of the aorta.
A neuromodulation catheter is positionable in a blood vessel having a wall for use in delivering therapeutic energy to targets external to the blood vessel. An electrically insulative substrate such as an elongate finger is carried at a distal end of the catheter body. The substrate has a first face carrying a plurality of electrodes, and a second face on an opposite side of the substrate from the first face. The finger is biased such that when expanded within the blood vessel, it forms a spiral configuration with the first face facing outwardly to bias the electrodes in contact with the blood vessel wall.
A61B 18/12 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
A device temporarily positionable within an aortic arch for deflecting embolic particles released during a therapeutic or diagnostic procedure comprises a resilient frame defining an opening and a barrier disposed in the opening. The barrier has a plurality of openings, which may be pores, proportioned to allow passage of blood therethrough but to prevent passage of embolic particles. The barrier has a concave shape having a convex surface positionable in contact with a wall of an aorta to cover at least a brachiocephalic ostium. The frame may include an upstream end including a pair of lobes and an apex between the lobes, and has a generally tapered downstream end.
A neuromodulation system for treating acute heart failure syndromes includes a first catheter having a parasympathetic therapy element adapted for positioning within a first blood vessel such as a superior vena cava, and a second catheter sympathetic therapy element adapted for positioning with a second, different, blood vessel such as the pulmonary artery. The catheters comprise a system in which one of catheters is slidably disposed over the other of the catheters. The system may further be slidably disposed over a third elongate element such as a Swan-Ganz catheter positionable within a pulmonary artery, such that the Swan- Ganz may be used for monitoring parameters such as blood pressure and cardiac output during neuromodulation therapy. The parasympathetic therapy element is energized to deliver neuromodulation therapy to a parasympathetic nerve fiber such as a vagus nerve, while the sympathetic therapy element is energized to deliver neuromodulation therapy to a sympathetic nerve fiber such as a sympathetic cardiac nerve fiber. For treatment of acute heart failure syndromes, the neuromodulation therapy may be used to lower heart rate and increase cardiac inotropy.
A61M 25/088 - Introducing, guiding, advancing, emplacing or holding catheters using an additional catheter, e.g. to reach relatively inaccessible places
A61B 18/00 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
An intravascular mapping and anchoring assembly is disclosed, comprising: a tubular sheath; an expandable anchor comprising a first portion and a second portion, each having a compressed position and an expanded position, the anchor having a fully compressed position in which the first and second portions are disposed in their compressed positions within the sheath; an array of electrodes mounted to the first portion; wherein the sheath is slidable retractable relative to the anchor to release the anchor from the fully compressed position to a mapping position in which the first portion is released from the sheath to an expanded position while the second portion remains in the compressed position within the sheath; and wherein the sheath is further slidable relative to the anchor to further release the second portion to an expanded position.
An energy storage component for use with an implantable intravascular medical device that maximizes the useful volume available in the implantable intravascular medical device by providing a bore in a capacitor or battery that allows connections between various segments of the implantable intravascular medical device to be connected with one another.
An energy harvesting device positionable within a blood vessel for use in generating energy for powering all or a portion of the functions of a diagnostic or therapeutic medical implant. The energy harvesting device includes piezoelectric elements arranged to generate a voltage in response to mechanical blood vessel activity such as bending, expansion or contraction of the blood vessel, or flow of blood through the blood vessel. The electrical energy generated by the piezoelectric elements may be used to recharge a battery, stored in a capacitor, and/or used in real time to generate the energy used for operation of the implant.
A percutaneously implantable device for the treatment of a cardiac condition or other disease is disclosed herein, the device capable of delivery and maintenance of a therapeutic scaffold. A therapeutic scaffold may comprise viable tissue to impart or restore normal cardiac function, or other therapeutic agent for the treatment of disease or injury. Viable tissue may comprise a pacemaker gene or other genes intended to impart a pacemaker function to either host tissue or transplanted tissue, or both. Further, a device according to the invention may be used for the implantation and maintenance of viable tissue to induce or enhance muscle contraction of a subject for the treatment of a disease or disorder.
A medical access system includes a cannula (10) and a plurality of access tubes (18) positioned in the cannula, each access tube including a proximal opening (20), a distal opening (22) and a collapsed section (24) between the proximal and distal openings'. The collapsed section is moveable to an expanded position in response to passage of an instrument into the lumen. The tubes are provided with a variety of cross-sectional 'diameters, allowing a user to elect to use a combination of tubes appropriate for the procedure being carried out. The collapsible nature of the tubes allows the cannula body' to contain a collection of tubes having cross- sections that, in combination, exceed the available space within the cannula body.
A system for minimally invasive medical procedures includes an elongate tubular access cannula comprising an elongate tubular member having a rigid proximal portion and an articulating portion. The tubular member has a first branch and a tubular bifurcation extending from the first branch, allowing simultaneous use of multiple instruments. A dissector suitable for use with the access cannula, or other access devices, for implantation of gastric bands or for other procedures includes a pre-curved distal portion having a dissection element such as a monopolar RF conductor and/or a dissection balloon, as well as a snare. In one method, the dissector is advanced around the posterior side of the stomach to form a tunnel in the connective tissue, and the snare is then extended from the dissector to engage a portion of the band and withdraw it through the tunnel.
A multi-instrument access device includes a base positionable within an opening (e.g. an incision or puncture) formed in a body wall and a dome-shaped seal on the base and positioned such that it is disposed outside the body wall during use. A plurality of instrument ports extend proximally from the seal for receiving instruments to be inserted into the body for use in a procedure. Tubular instrument tubes having pre-curved distal ends may be insertable through the ports for receiving the instruments and for orienting the operative ends of the instruments toward a target site.
Satiation devices for controlling obesity and methods of implanting same are configured to create a small satiation pouch in the proximal portion of the stomach with a narrow passage leading into the lower portion of the stomach. The small satiation pouch is configured to collect a small amount of masticated food from the esophagus and the narrow passage delays emptying of the food from the satiation pouch into the larger part of the stomach, thereby causing a feeling of fullness.
A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
27.
DEVICES FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE AND HIATAL HERNIA, AND METHODS OF TREATING GASTROESOPHAGEAL REFLUX DISEASE AND HIATAL HERNIA USING SAME
A device for treating GERD includes a pair of sections. Each section includes a proximal end portion with an arcuate interior opening, a distal end portion with an arcuate interior opening, an exterior plate portion, and a tapered body portion extending from the proximal end portion to the distal end portion. The pair of sections surround the esophagus at the gastro-esophageal junction thereof and to be secured together to form a tubular housing with a proximal orifice, a distal orifice smaller than the proximal orifice, and a plate adjacent the distal orifice. A portion of the housing adjacent the distal orifice is configured to elastically deform to constrict the esophagus and serve the function of the LES when a force is applied to the plate by the fundus. The proximal end portion of each mating section includes a flange portion configured to be attached to a body cavity wall.
In a method for sealing an incision in an interior body wall such as a gastrotomy opening in a stomach, a closure device (10) is positioned within the incision. The closure device includes a seal (12b) and an anchor (12a) coupled to the seal. The seal is positioned in sealing contact against a first surface surface of the body wall, and the anchor is positioned against the second surface of the body wall such that a portion of the closure device is positioned. The closure device seals the incision while healing takes place. Once the incision is significantly healed, the closure device bioerodes.
A gastric implant system includes a gastric implant such as a restrictive pouch or a gastric balloon, an anchor passable through the mouth and stomach and further through the stomach wall into engageable with abdominal wall tissue. When the anchor is engaged to abdominal wall tissue, the stomach wall and abdominal wall are brought into contact with one another such that a proximal portion of the anchor extends into the stomach interior while a distal portion of the anchor remains engaged to the abdominal wall. A locking element coupled to the proximal section of the anchor is used to maintain contact between the stomach wall and abdominal wall. The gastric implant is advanced through the oral cavity into the stomach and is coupled to the anchor.
An intestinal implant includes a proximal anchor self-expandable from a radially compressed position to a radially expandable position for engagement with a wall of the intestinal lumen and a flexible sleeve coupled to the anchor. The sleeve is implanted with the anchor downstream from the pylorus and the sleeve extending further downstream through the intestinal lumen.
In a first embodiment of a system for treating diseased bowel, a pair of incisions are formed on opposite ends of a diseased section of bowel. A tubular bypass implant is positioned in the bowel such that its ends are anchored within the bowel and such that an intermediate section of the implant is positioned external to the bowel such that bowel contents flow through the implant and thus around the diseased bowel section. In a second embodiment, the diseased section of bowel is removed and a system is implanted for joining limbs of the resected bowel together to form an anastomosis. In the preferred anastomosis system, the limbs of the resected bowel are positioned between a tubular sleeve extending through the bowel and a tubular cuff positioned around the bowel.
A61B 17/11 - Surgical instruments, devices or methods for closing wounds or holding wounds closedAccessories for use therewith for performing anastomosisButtons for anastomosis
A61F 2/04 - Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
A61F 2/82 - Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
32.
MULTI -INSTRUMENT SURGICAL ACCESS USING A SINGLE ACCESS PORT
A system for performing multi-tool minimally invasive medical procedures through a single instrument port into a body cavity includes an expandable frame that carries a pair of tool cannulas, each of which has a lumen for receiving a tool useable to perform a procedure in the body cavity. The frame is expandable to orient the tool cannulas such that they allow the tools to be used in concert to carry out a procedure at a common location in the body cavity.
A61B 1/018 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor characterised by internal passages or accessories therefor for receiving instruments
A system for performing minimally invasive medical procedures through a natural orifice includes an elongate support advanceable in a flexible state through a natural orifice and through an incision in a body organ into a body cavity. The elongate support is convertible to a rigid state within the body cavity. The elongate support supports a frame that carries a pair of tool cannulas, each of which has a lumen for receiving a tool useable to perform a procedure in the body cavity. The frame is expandable to orient the tool cannulas such that they allow the tools to be used in concert to carry out a procedure at a common location in the body cavity.
A61B 1/018 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor characterised by internal passages or accessories therefor for receiving instruments
Intravascular devices are delivered to the aorta percutaneously via the femoral artery. The devices (12) are anchored (10) within the vasculature in the region of the renal artery ostia. These embodiments function to increase the flow of blood from the aorta to the renal arteries, thus, delivering a higher relative percentage of the blood flowing through the aorta to the kidneys. The elevation in blood low to the kidneys improves the natural removal of excess fluids from the body. In one embodiment, the device is a diverter element positionable upstream of the renal artery ostia. In another embodiment, the device is a flow restrictor positionable downstream of the ostia to cause an elevation is pressure upstream of the ostia.
The present disclosure describes intravascular systems that may be used for a variety of functions. The elements of the disclosed systems include at least one device body implanted within the vasculature. Electrodes on a lead and/or on the device body itself are used to direct electrical energy to neurological targets. These systems may additionally include one or more fluid reservoirs housing drugs or other agents to be delivered to tissue.
Embodiments of surgical access cannulas and access systems for use in gaining access to a body cavity of a patient via a natural orifice are disclosed. A distal end of an access cannula is advanced through a natural orifice into a hollow organ. Instruments passed through the cannula are used to form an incision in the wall of the hollow organ. The access cannula is anchored in the incision with its distal opening giving access to a body cavity outside the hollow organ. Surgical instruments are passed through the access cannula and used to perform procedures in the body cavity.
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (USA)
NORTH CAROLINA STATE UNIVERSITY (USA)
SYNECOR, LLC (USA)
Inventor
Desimone, Joseph, M.
Williams, Michael, S.
Portnow, Lauren
Wood, Colin
Zhou, Zhilian
Baucom, Everett
Rothrock, Ginger, Denison
Abstract
The presently disclosed subject matter describes acid-derivatized perfluoropolyether (PFPE) materials and their use as coatings, sealants, and flexible fillers for devices, apparatuses, and structural parts for a variety of medical applications, and as coatings, sealants, flexible fillers, and structural parts for vessels, structures, and machinery exposed to a marine environment.
B05D 3/06 - Pretreatment of surfaces to which liquids or other fluent materials are to be appliedAfter-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials by exposure to radiation
A device for implantation in the vasculature of a patient can include a fixation mechanism for anchoring the device in place while allowing for easy removal of the device. The fixation mechanism can include a detachable and/or biodegradable portion that can allow for removal from the bulk of the device in order to allow for the bulk to simply be pulled from the body without likelihood of injury. These devices also can include electrode assemblies that do not promote fibrous ingrowth, further reducing the likelihood for injury upon extraction of the device.
A device for implantation in the vasculature of a patient can include discrete but electrically connected electrodes that, along with the device body, form a substantially smooth exterior surface that allows for easy insertion and removal. Any interstices between the electrodes can be back-filled with a flexible elastomer such as silicone to ensure a smooth surface. The individual electrode segments, such as ring or disc segments, can be connected by an appropriate conductive connection, such as a flexible u-joint, thru-cable, or end-to-end connection including a coupler spring.
